Literature DB >> 25292018

MicroRNAs: biogenesis, roles for carcinogenesis and as potential biomarkers for cancer diagnosis and prognosis.

Nowroji Kavitha1, Soundararajan Vijayarathna, Subramanion Lachumy Jothy, Chern Ein Oon, Yeng Chen, Jagat Rakesh Kanwar, Sreenivasan Sasidharan.   

Abstract

MicroRNAs (miRNAs) are short non-coding RNAs of 20-24 nucleotides that play important roles in carcinogenesis. Accordingly, miRNAs control numerous cancer-relevant biological events such as cell proliferation, cell cycle control, metabolism and apoptosis. In this review, we summarize the current knowledge and concepts concerning the biogenesis of miRNAs, miRNA roles in cancer and their potential as biomarkers for cancer diagnosis and prognosis including the regulation of key cancer-related pathways, such as cell cycle control and miRNA dysregulation. Moreover, microRNA molecules are already receiving the attention of world researchers as therapeutic targets and agents. Therefore, in-depth knowledge of microRNAs has the potential not only to identify their roles in cancer, but also to exploit them as potential biomarkers for cancer diagnosis and identify therapeutic targets for new drug discovery.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25292018     DOI: 10.7314/apjcp.2014.15.18.7489

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  21 in total

1.  miR-422a is an independent prognostic factor and functions as a potential tumor suppressor in colorectal cancer.

Authors:  Gui-Xi Zheng; Ai-Lin Qu; Yong-Mei Yang; Xin Zhang; Shou-Cai Zhang; Chuan-Xin Wang
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

2.  The role of miR-370 and miR-138 in the regulation of BMP2 suppressor gene expression in colorectal cancer: preliminary studies.

Authors:  Agnieszka Piechowska; Celina Kruszniewska-Rajs; Magdalena Kimsa-Dudek; Magdalena Kołomańska; Barbara Strzałka-Mrozik; Joanna Gola; Stanisław Głuszek
Journal:  J Cancer Res Clin Oncol       Date:  2022-03-15       Impact factor: 4.553

3.  miR-663b promotes colorectal cancer progression by activating Ras/Raf signaling through downregulation of TNK1.

Authors:  Sen Hong; Zhenkun Yan; Helei Wang; Lei Ding; Yumei Song; Miaomiao Bi
Journal:  Hum Cell       Date:  2019-11-23       Impact factor: 4.174

4.  Novel MicroRNA signatures in HPV-mediated cervical carcinogenesis in Indian women.

Authors:  Shweta Sharma; Showket Hussain; Kartik Soni; Pallavi Singhal; Richa Tripathi; V G Ramachandran; Sonal Sharma; Shukla Das; Beena Pillai; Mausumi Bharadwaj
Journal:  Tumour Biol       Date:  2015-10-27

5.  Circulating microRNA-122 as Potential Biomarker for Detection of Testosterone Abuse.

Authors:  Olivier Salamin; Laetitia Jaggi; Norbert Baume; Neil Robinson; Martial Saugy; Nicolas Leuenberger
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

6.  LncRNA Snhg1, a non-degradable sponge for miR-338, promotes expression of proto-oncogene CST3 in primary esophageal cancer cells.

Authors:  Yan Yan; Qingxia Fan; Liping Wang; Yue Zhou; Jianhua Li; Kun Zhou
Journal:  Oncotarget       Date:  2017-05-30

7.  MiR-30e-5p inhibits the migration and invasion of nasopharyngeal carcinoma via regulating the expression of MTA1.

Authors:  Weiqun Hu; Wenfeng Yao; Haolin Li; Li Chen
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

8.  Meta-analysis of the differentially expressed microRNA profiles in nasopharyngeal carcinoma.

Authors:  Junwen Luan; Junfu Wang; Qinghong Su; Xuemei Chen; Guosheng Jiang; Xiaoqun Xu
Journal:  Oncotarget       Date:  2016-03-01

9.  Influence of Adalimumab on the Expression Profile of Genes Associated with the Histaminergic System in the Skin Fibroblasts In Vitro.

Authors:  Dominika Wcisło-Dziadecka; Beniamin Grabarek; Nikola Zmarzły; Aleksandra Skubis; Bartosz Sikora; Celina Kruszniewska-Rajs; Joanna Gola; Urszula Mazurek; Eugeniusz Kucharz
Journal:  Biomed Res Int       Date:  2018-01-02       Impact factor: 3.411

10.  miR-15b enhances the proliferation and migration of lung adenocarcinoma by targeting BCL2.

Authors:  Jun Wang; Shupeng Yao; Yanping Diao; Yan Geng; Yanling Bi; Guangyue Liu
Journal:  Thorac Cancer       Date:  2020-03-27       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.